Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study.

Persico M, Aglitti A, Milella M, Coppola C, Messina V, Claar E, Gentile I, Sogari F, Pierri P, Surace LA, Morisco F, Tundo P, Brancaccio G, Serviddio G, Gatti P, Termite AP, Di Costanzo GG, Caroleo B, Cozzolongo R, Coppola N, Longo A, Fontanella L, Federico A, Rosato V, Terrenato I, Masarone M.

Liver Int. 2019 Jun 7. doi: 10.1111/liv.14170. [Epub ahead of print]

PMID:
31175707
2.

High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients.

Pellicelli A, Messina V, Giannelli V, Distefano M, Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri S, Dell'Isola S, Marignani M, Scifo G, Iovinella V, Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito AM, Barbarini G; Working Group CLEO.

Gut Liver. 2019 Aug 14. doi: 10.5009/gnl18269. [Epub ahead of print]

3.

Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.

Rinaldi L, Guarino M, Perrella A, Pafundi PC, Valente G, Fontanella L, Nevola R, Guerrera B, Iuliano N, Imparato M, Trabucco A, Sasso FC, Morisco F, Ascione A, Piai G, Adinolfi LE.

Dig Dis Sci. 2019 Apr 1. doi: 10.1007/s10620-019-05604-8. [Epub ahead of print]

PMID:
30937719
4.

Predictive functional ANOVA models for longitudinal analysis of mandibular shape changes.

Fontanella L, Ippoliti L, Valentini P.

Biom J. 2019 Jul;61(4):918-933. doi: 10.1002/bimj.201800228. Epub 2019 Mar 13.

PMID:
30865334
5.

Aging and the Combined effects of ADRA2B and CB1 deletions on Affective Working Memory.

Fairfield B, Mammarella N, Fontanella L, Sarra A, D'Aurora M, Stuppia L, Gatta V.

Sci Rep. 2019 Mar 11;9(1):4081. doi: 10.1038/s41598-019-40108-5.

6.

Simple Structure Detection Through Bayesian Exploratory Multidimensional IRT Models.

Fontanella L, Fontanella S, Valentini P, Trendafilov N.

Multivariate Behav Res. 2019 Jan-Feb;54(1):100-112. doi: 10.1080/00273171.2018.1496317. Epub 2018 Nov 7.

PMID:
30403887
7.

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.

Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group.

Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28.

PMID:
29808463
8.

Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.

Rinaldi L, Ascione A, Messina V, Rosato V, Valente G, Sangiovanni V, Zampino R, Marrone A, Fontanella L, de Rosa N, Orabona P, Buonomo C, Chirianni A, Adinolfi LE, Piai G.

Infection. 2018 Apr;46(2):231-238. doi: 10.1007/s15010-017-1113-1. Epub 2018 Jan 15.

PMID:
29335905
9.

Virological patterns of HCV patients with failure to interferon-free regimens.

Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Adinolfi LE, Claar E, Precone D, Stornaiuolo G, Stanzione M, Ascione T, Caroprese M, Zampino R, Parrilli G, Gentile I, Brancaccio G, Iovinella V, Martini S, Masarone M, Fontanella L, Masiello A, Sagnelli E, Punzi R, Salomone Megna A, Santoro R, Gaeta GB, Coppola N.

J Med Virol. 2018 May;90(5):942-950. doi: 10.1002/jmv.25022. Epub 2018 Feb 1.

PMID:
29315640
10.

Negative Affectivity Predicts Lower Quality of Life and Metabolic Control in Type 2 Diabetes Patients: A Structural Equation Modeling Approach.

Conti C, Di Francesco G, Fontanella L, Carrozzino D, Patierno C, Vitacolonna E, Fulcheri M.

Front Psychol. 2017 May 24;8:831. doi: 10.3389/fpsyg.2017.00831. eCollection 2017.

11.

Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.

Macera M, Stanzione M, Messina V, D'Adamo G, Sangiovanni V, Mioglioresi L, Fontanella L, De Pascalis S, Stornaiuolo G, Galeota Lanza A, Ascione T, Sagnelli E, Gentile I, Piai G, Gaeta GB, Coppola N.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1800-1802. doi: 10.1016/j.cgh.2017.05.032. Epub 2017 May 26. No abstract available.

PMID:
28552801
12.

HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.

Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fontanella L, Lauletta G, Cuccorese G, Metrangolo A, Francavilla R, Ciracì E, Rizzo S, Andriulli A.

Dig Liver Dis. 2017 Sep;49(9):1022-1028. doi: 10.1016/j.dld.2017.03.025. Epub 2017 Apr 8.

13.

Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.

Ascione A, Fontanella L, Imparato M, Rinaldi L, De Luca M.

Liver Int. 2017 Aug;37(8):1193-1201. doi: 10.1111/liv.13371. Epub 2017 Mar 5.

PMID:
28111883
14.

Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.

Cleo Study Group, Ascione A, Adinolfi LE, Amoroso P, Andriulli A, Armignacco O, Ascione T, Babudieri S, Barbarini G, Brogna M, Cesario F, Citro V, Claar E, Cozzolongo R, D'Adamo G, D'Amico E, Dattolo P, De Luca M, De Maria V, De Siena M, De Vita G, Di Giacomo A, De Marco R, De Stefano G, De Stefano G, Di Salvo S, Di Sarno R, Farella N, Felicioni L, Fimiani B, Fontanella L, Foti G, Furlan C, Giancotti F, Giolitto G, Gravina T, Guerrera B, Gulminetti R, Iacobellis A, Imparato M, Iodice A, Iovinella V, Izzi A, Liberti A, Leo P, Lettieri G, Luppino I, Marrone A, Mazzoni E, Messina V, Monarca R, Narciso V, Nosotti L, Pellicelli AM, Perrella A, Piai G, Picardi A, Pierri P, Pietromatera G, Resta F, Rinaldi L, Romano M, Rossini A, Russello M, Russo G, Sacco R, Sangiovanni V, Schiano A, Sciambra A, Scifo G, Simeone F, Sullo A, Tarquini P, Tundo P, Vallone A.

World J Hepatol. 2016 Aug 8;8(22):949-56. doi: 10.4254/wjh.v8.i22.949.

15.

Quantile regression and Bayesian cluster detection to identify radon prone areas.

Sarra A, Fontanella L, Valentini P, Palermi S.

J Environ Radioact. 2016 Nov;164:354-364. doi: 10.1016/j.jenvrad.2016.06.014. Epub 2016 Aug 24.

PMID:
27567147
16.

Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection.

Ascione A, De Luca M, Tartaglione MT, Lampasi F, Di Costanzo GG, Lanza AG, Picciotto FP, Marino-Marsilia G, Fontanella L, Leandro G.

Gastroenterology. 2010 Jan;138(1):116-22. doi: 10.1053/j.gastro.2009.10.005. Epub 2009 Oct 20.

PMID:
19852964
17.

Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables.

Rosato E, Maione S, Vitarelli A, Giunta A, Fontanella L, de Horatio LT, Cacciatore F, Proietti M, Pisarri S, Salsano F.

Rheumatol Int. 2009 Jun;29(8):913-9. doi: 10.1007/s00296-008-0827-x. Epub 2008 Dec 28.

PMID:
19112565
18.

Prognostic value of reduced kidney function and anemia in patients with chronic heart failure.

Petretta M, Scopacasa F, Fontanella L, Carlomagno A, Baldissara M, de Simone A, Petretta MP, Bonaduce D.

J Cardiovasc Med (Hagerstown). 2007 Nov;8(11):909-16.

PMID:
17906476
19.

NT-proBNP, IGF-I and survival in patients with chronic heart failure.

Petretta M, Colao A, Sardu C, Scopacasa F, Marzullo P, Pivonello R, Fontanella L, de Caterina M, de Simone A, Bonaduce D.

Growth Horm IGF Res. 2007 Aug;17(4):288-96. Epub 2007 Mar 23.

PMID:
17383209
20.

Effects of volume loading on strain rate and tissue Doppler velocity imaging in patients with idiopathic dilated cardiomyopathy.

Vicario ML, Caso P, Martiniello AR, Fontanella L, Petretta M, Sardu C, Petretta MP, Bonaduce D.

J Cardiovasc Med (Hagerstown). 2006 Dec;7(12):852-8.

PMID:
17122670
21.

Influence of risk factors on coronary flow reserve in patients with 1-vessel coronary artery disease.

Vicario ML, Cirillo L, Storto G, Pellegrino T, Ragone N, Fontanella L, Petretta M, Bonaduce D, Cuocolo A.

J Nucl Med. 2005 Sep;46(9):1438-43.

22.

Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.

Peretto I, Radaelli S, Parini C, Zandi M, Raveglia LF, Dondio G, Fontanella L, Misiano P, Bigogno C, Rizzi A, Riccardi B, Biscaioli M, Marchetti S, Puccini P, Catinella S, Rondelli I, Cenacchi V, Bolzoni PT, Caruso P, Villetti G, Facchinetti F, Del Giudice E, Moretto N, Imbimbo BP.

J Med Chem. 2005 Sep 8;48(18):5705-20.

PMID:
16134939
23.

Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine.

Garnier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rhee MH, Blumer KJ, Scheideler MA.

J Pharmacol Exp Ther. 2003 Mar;304(3):1299-306. Erratum in: J Pharmacol Exp Ther. 2003 May;305(2):797.

PMID:
12604710
24.

Characterization and properties of dominant-negative mutants of the ras-specific guanine nucleotide exchange factor CDC25(Mm).

Vanoni M, Bertini R, Sacco E, Fontanella L, Rieppi M, Colombo S, Martegani E, Carrera V, Moroni A, Bizzarri C, Sabbatini V, Cattozzo M, Colagrande A, Alberghina L.

J Biol Chem. 1999 Dec 17;274(51):36656-62.

25.

Photometric assay for polynucleotide phosphorylase.

Fontanella L, Pozzuolo S, Costanzo A, Favaro R, Dehò G, Tortora P.

Anal Biochem. 1999 May 1;269(2):353-8.

PMID:
10222010
26.

[Synthesis and pharmacologic activity of derivatives of 3-aminopropiophenone and 3-aminomethylcamphor].

Occelli E, Fontanella L, Diena A, Schiatti P.

Farmaco Sci. 1985 Feb;40(2):86-101. Italian.

PMID:
3873354
27.

Metabolism of the neuroleptic agent zetidoline in the rat and the dog.

Assandri A, Perazzi A, Fontanella L, Ferrari P, Ripamonti A, Tarzia G, Tuan G, Martinelli E.

Drug Metab Dispos. 1984 Sep-Oct;12(5):635-40.

PMID:
6149917
28.

[Substances with central nervous system activity. Derivatives of octahydro-1,4-dihydroxypyrrolo(1,2-a)pyrazine-6-carboxylic acids].

Occelli E, Mariani L, Fontanella L, Corsico N.

Farmaco Sci. 1984 Aug;39(8):718-38. Italian.

PMID:
6541160
29.
30.

[Derivatives of 2,3,5,6,7,7a-hexahydro-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol -5-carboxylic acids].

Fontanella L, Corsico N, Diena A, Occelli E.

Farmaco Sci. 1984 Feb;39(2):133-53. Italian.

PMID:
6143686
31.

Synthesis of new psychotropic 2-imidazolidinones.

Fontanella L, Corsico N, Diena A, Galliani G, Glässer A.

Farmaco Sci. 1981 Jan;36(1):3-12.

PMID:
7202707
32.

[Tricyclic homologs of piperazine. III. Synthesis of 4-substituted hexahydro-1H-2,6-methanopyrrolo[1,2a]pyrazines].

Occelli E, Fontanella L, Testa E.

Farmaco Sci. 1978 Nov;33(11):875-84. Italian.

PMID:
154414
33.
34.
35.

[Synthesis of 1-and 3-phenyl substituted 1,5-dihydro-2,4-benzoxazepin-3(4H)-ones].

Fontanella L, Mariani L.

Farmaco Sci. 1975 Oct;30(10):773-88. Italian.

PMID:
1183597
36.
37.

[Synthesis of hexahydropyrrolo (1,2-c)imidazolones, substituted in 2,5 and 2,3,5 positions].

Fontanella L, Occelli E, Perazzi A.

Farmaco Sci. 1973 Jun;28(6):463-77. Italian. No abstract available.

PMID:
4716497
38.

[Substances active on the central nervous system. LI (1) N-substituted 3,3-di-n-propylazetidin-2-ones].

Fontanella L, Mariani L, Testa E.

Farmaco Sci. 1973 Jun;28(6):448-62. Italian. No abstract available.

PMID:
4716496
39.

[Substances active on the C.N.S. L. Synthesis of 3-ethyl-3-phenylazetidin-2-ones with substitutions on the aromatic ring].

Fontanella L, Pifferi G, Testa E, Consonni P.

Farmaco Sci. 1973 Feb;28(2):105-15. Italian. No abstract available.

PMID:
4692786
40.
41.

[Synthesis of new 3-monosubstituted azetidinones and 3,3-disubstituted 1-aminoazetidinones as potential anti-inflammatory agents].

Fontanella L, Testa E, Pifferi G.

Farmaco Sci. 1972 Jul;27(7):527-37. Italian. No abstract available.

PMID:
5079476
42.

[Bicyclic homologues of piperazine. XI (1). Derivatives of 3,8-diazabicyclo-(3.2.1)-octane-2,4-diones with potential pharmacologic activity].

Fontanella L, Occelli E.

Farmaco Sci. 1972 Jan;27(1):68-78. Italian. No abstract available.

PMID:
4666526
43.

[1,6-Diazabicyclo(4,3,O)nonan-2,7-diones and derivatives].

Testa E, Fontanella L.

Farmaco Sci. 1971 Dec;26(12):1017-35. Italian. No abstract available.

PMID:
5144290
44.

[1,6-diazabicyclo-(4.4.0)-decan-2,7-diones and derivatives].

Testa E, Fontanella L.

Farmaco Sci. 1971 Nov;26(11):950-7. Italian. No abstract available.

PMID:
5143144
45.
46.

[New thioxanthene derivatives with central nervous activity].

Fontanella L, Mariani L, Occelli E, Rosselli del Turco B, Diena A.

Farmaco Sci. 1971 Jun;26(6):489-511. Italian. No abstract available.

PMID:
5561806
47.

[2-(1-hydantoin) propionic acids].

Fontanella L.

Farmaco Sci. 1970 Jul;25(7):542-61. Italian. No abstract available.

PMID:
5455048
48.

[Bicyclic homologs of piperazine. 8. Synthesis and characteristics of 3,8-diazabicyclo-(3.2.1.)-octan-2-one].

Testa E, Cignarella G, Fontanella L, Occelli E.

Farmaco Sci. 1969 Apr;24(4):418-34. Italian. No abstract available.

PMID:
5772130
49.

[Substances acting on the central nervous system. 49. Synthesis and chemical properties of azetidine-2-thiones].

Testa E, Fontanella L.

Farmaco Sci. 1968 Jul;23(7):642-53. Italian. No abstract available.

PMID:
5670109
50.

[Derivatives of phenylbutyrates. 3. Synthesis of compounds with potential anti-inflammatory activity correlated to 3,3'-diphenyl-N,N'-dipyrrolidine-2,2'-dione].

Cignarella G, Fontanella L, Aresi V, Testa E.

Farmaco Sci. 1968 Apr;23(4):321-43. Italian. No abstract available.

PMID:
5680376

Supplemental Content

Loading ...
Support Center